Alok Khorana: Rivaroxaban Prevents Cancer-Associated VTE
1,242 views · Published 12 December 2018 · 5:36 · Indexed 6 October 2026
Channel: American Society of Hematology · 2018 · Nonprofits & Activism
Dr. Khorana shares results from the CASSINI trial, which found that treatment with rivaroxaban reduced the risk of venous thromboembolism in patients with cancer.
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding
-
3:13
Meet the Editor: A. Keith Stewart, MBChB